Course Directors

Gunter Hoeglinger, MD - Medical School Hannover, Hannover, Germany
Brit Mollenhauer, MD - Paracelsus-Elena Klinik and University Medical Center Goettingen, Kassel, Germany
Tiago Outeiro, PhD - University Medical Center Goettingen, Goettingen, Germany

Faculty 
Franziska Hopfner, MD, PhD - Hannover Medical School, Hannover, Germany
Hilal Lashuel, PhD - Swiss Federal Institute of Technology Lausanne, Lausanne, Switzerland
Wassilios Meissner, MD, PhD - Institute for Neurodegenerative Diseases, University of Bordeaux, Bordeaux, France
Laura Parkkinen, PhD - University of Oxford, Oxford, United Kingdom
John Taylor, MD, PhD - Newcastle University, Newcastle upon Tyne, United Kingdom
Claudia Trenkwalder, MD, FEAN - Paracelsu- Elena Klinik, Kassel, Germany
Paul Wilmes, PhD - Luxembourg Centre for Systems Biomedicine, University of Luxembourg, Esch-sur-Alzette, Luxembourg

The primary purpose of this course is to provide information on the basic science of alpha-synuclein aggregation disorders and on how this knowledge is being translated into clinical applications.

Registration Fees

Members: $15 USD
No Fee Members: $5 USD

Non-Members: $50 USD

*Non-members wishing to apply for MDS Membership to receive the MDS Member rate for this course will need to apply for membership no later than 2 weeks in advance of session.

Registration closes May 16, 2022.

Upon completion of this activity learners will be able to:

1. Recognize the genetic and neuropathological connections of alpha-synuclein with movement disorders

2. Define current efforts in the use of alpha-synuclein as a biomarker

3. Identify therapeutic strategies targeting alpha-synuclein for treating synucleinopathies

This course is intended for clinical research fellows, neurology residents and basic science and translational researchers.

To see a detailed schedule, please click HERE